Related Experiment Video
Updated: Apr 28, 2026

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
Predictors of Cerebrovascular Accident Among Sudanese Children with Sickle Cell Anemia
1Department of Child Health, College of Medicine, University of Bisha, PO Box 1290, 61922 Bisha, Kingdom of Saudi Arabia.
Insights
Sickle cell disease (SCD) patients, particularly those aged 2-5, face high risks of stroke. Limited access to preventive care like transcranial Doppler (TCD) and blood transfusions exacerbates this risk.
Area of Science:
- Neurology
- Hematology
- Pediatrics
Background:
- Sickle cell disease (SCD) is an inherited blood disorder characterized by abnormal hemoglobin.
- Neurological complications, including cerebrovascular accidents (CVA), are severe and common in SCD patients.
- Preventive measures like transcranial Doppler (TCD) screening and blood transfusions are crucial for reducing stroke risk.
Purpose of the Study:
- To evaluate the prevalence and impact of neurological complications, specifically CVA, in Sudanese children with SCD.
- To identify risk factors and predictors associated with CVA in this population.
- To highlight challenges in accessing preventive care for SCD patients in the region.
Main Methods:
- Retrospective review of medical records of SCD patients aged 2-15 years at Albuluk Children's Hospital (2017-2019).
- Exclusion of patients with other central nervous system (CNS) conditions.
- Analysis of demographic, clinical, and socioeconomic factors associated with CVA.
Main Results:
- A CVA prevalence of 11.1% was observed among 117 SCD patients.
- Risk factors identified include younger age (2-5 years), chest syndrome, severe anemia, and elevated white blood cell (WBC) counts.
- Low-moderate socioeconomic status and a positive family history were associated with 76.9% of CVA cases.
- Limited access to TCD, MRI, and regular blood transfusions presented significant barriers to care.
Conclusions:
- Stroke prevalence in SCD is significantly higher in regions with limited access to advanced preventive measures.
- Early identification of high-risk individuals and improved access to TCD, MRI, and transfusions are critical for preventing CVA in SCD.
- Targeted interventions addressing socioeconomic factors and providing comprehensive care are essential for improving outcomes in Sudanese SCD patients.
Abstract:
Sickle cell disease (SCD) is an inherited condition caused by abnormal hemoglobin, leading to severe complications like strokes and silent cerebral infarcts. Early screening with transcranial Doppler and regular blood transfusions significantly reduce stroke risk. Updated guidelines emphasize these preventive measures for better outcomes. The study aims to evaluate the prevalence of neurological complications, such as CVA, among Sudanese SCD patients and estimate their impact. This study reviewed records of SCD patients aged 2-15 at Albuluk Children's Hospital (2017-2019), excluding those with other CNS conditions. The study of 117 SCD patients found that 11.1% developed CVA, with (76.9%) of cases linked to low-moderate socioeconomic status, positive family history, severe anemia, and high WBC levels. Limited access to TCD, MRI, and blood transfusion posed significant challenges. Key predictors of stroke in SCD patients include age 2-5 years, chest syndrome, low hemoglobin levels, and high WBC counts. Stroke prevalence is higher in regions lacking advanced preventive measures like TCD, MRI, and regular blood transfusions.
More Related Videos
Related Concept Videos
Hemorrhagic Stroke l: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Hemorrhagic Stroke ll: Pathophysiology

